Roof Eidam & Maycock Abb Vie Inc. Transaction History

Roof Eidam & Maycock

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $997,125 - $1.11 Million	-11,215 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $27,382 - $32,400	305 Added 2.8%	11,215 $1.04 Million
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $127,893 - $171,261	1,390 Added 14.6%	10,910 $1.03 Million
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $181,359 - $198,875	2,025 Added 27.02%	9,520 $921,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $523,525 - $668,703	7,495	7,495 $666,000

3,699

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Roof Eidam & Maycock, based on Form 13F filings with the SEC.

Stay updated on Roof Eidam & Maycock with notifications on news.